- Home
- OPTN vs SATX Comparison
OPTN vs SATX Comparison
Compare OPTN & SATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- SATX
- Stock Information
- Founded
- OPTN 2010
- SATX 2012
- Country
- OPTN United States
- SATX Israel
- Employees
- OPTN N/A
- SATX N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- SATX Radio And Television Broadcasting And Communications Equipment
- Sector
- OPTN Health Care
- SATX Technology
- Exchange
- OPTN Nasdaq
- SATX Nasdaq
- Market Cap
- OPTN 78.4M
- SATX 72.1M
- IPO Year
- OPTN 2017
- SATX N/A
- Fundamental
- Price
- OPTN $0.45
- SATX $1.19
- Analyst Decision
- OPTN Strong Buy
- SATX Buy
- Analyst Count
- OPTN 3
- SATX 1
- Target Price
- OPTN $3.00
- SATX $2.00
- AVG Volume (30 Days)
- OPTN 1.2M
- SATX 115.7K
- Earning Date
- OPTN 11-12-2024
- SATX 02-14-2025
- Dividend Yield
- OPTN N/A
- SATX N/A
- EPS Growth
- OPTN N/A
- SATX N/A
- EPS
- OPTN N/A
- SATX N/A
- Revenue
- OPTN $75,672,000.00
- SATX $10,351,000.00
- Revenue This Year
- OPTN $13.42
- SATX $80.62
- Revenue Next Year
- OPTN $52.99
- SATX N/A
- P/E Ratio
- OPTN N/A
- SATX N/A
- Revenue Growth
- OPTN 5.13
- SATX N/A
- 52 Week Low
- OPTN $0.32
- SATX $0.30
- 52 Week High
- OPTN $2.10
- SATX $1.30
- Technical
- Relative Strength Index (RSI)
- OPTN 39.55
- SATX 81.64
- Support Level
- OPTN $0.42
- SATX $0.80
- Resistance Level
- OPTN $0.57
- SATX $1.30
- Average True Range (ATR)
- OPTN 0.05
- SATX 0.11
- MACD
- OPTN 0.00
- SATX 0.04
- Stochastic Oscillator
- OPTN 26.39
- SATX 97.38
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.